Acquisition - June 25, 2019
Karo Pharma acquires Trimb
The company has acquired all the shares of Trimb Holding AB from Avista Capital Partners and other shareholders for MSEK 3,400. The transaction is expected to contribute positively to Karo Pharma’s market position and create a strong platform for Karo Pharma’s continued growth. The combined company had annual sales of approximately MSEK 2,640 for 2018. […]
In a new job - April 8, 2019
He is the new CEO of Karo Pharma
The Board of the company has appointed Christoffer Lorenzen as the new CEO, replacing Peter Blom. Christoffer Lorenzen, born 1975, is currently an Executive Vice President and member of the Executive Board of Chr. Hansen Holding A/S, which is listed on the Copenhagen Stock Exchange. He holds an M.Sc. in Marketing from the Copenhagen Business […]
Acquisition - November 2, 2016
Karo Pharma acquires BioPhausia
Medivir has entered into an agreement with Karo Pharma regarding the sale of its subsidiary BioPhausia. The purchase price will be SEK 908 million on a cash and debt free basis, including a normalized working capital an the transaction is expected to close by mid-December 2016. As previously communicated the Board of Directors of Medivir tasked […]
